$CCRN

Allen Dwayne sold (to issuer) $415K of CCRN

Allen Dwayne sold (to issuer) 31,289 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($0.41M total) on 2026-07-21.

Original reporting
SEC EDGAR · Allen Dwayne
Published Jul 21, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
medium confidence
Mentioned
$CCRN
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The newest fact is the director’s sale of 31,289 shares to the issuer for $414,579.25 at $13.25 on 2026-07-21.

02

Market read

Traders may note insider selling, but the disclosure alone is unlikely to drive a durable repricing without accompanying operational or guidance news.

03

What to watch

No 10b5-1 plan is stated, but the filing does not provide intent or future trading; also, the director ends with 0 shares, which can reflect diversification rather than timing.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-21, after-hours/late day SEC Form 4 disclosure.

Background

The article is an SEC Form 4 insider transaction disclosure for Cross Country Healthcare (CCRN).

Company-level read

Ticker impact

$CCRNNeutralMedium confidence
Context

Cross Country Healthcare director Allen Dwayne sold 31,289 shares to the issuer for about $414.6K at $13.25 on 2026-07-21.

Expected impact

Low near-term impact; any effect is likely sentiment-only and should fade unless follow-on insider activity or fundamentals change.

Evidence & confidence

Form 4 shows a director sale to issuer at a fixed price, with holdings after transaction at 0 shares and no 10b5-1 plan noted. This is typically not a fundamental catalyst by itself, but it can slightly affect sentiment around insider confidence.

Market effects

None; this is company-specific insider transaction data.

None.

None.

Counterpoint

Because the code indicates sale to issuer, the transaction may be mechanical (e.g., buyback participation) rather than a bearish view on prospects.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Subject of the Form 4 insider transaction disclosure.

  • Allen Dwayne

    Director who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).